Filing Details
- Accession Number:
- 0001127602-10-028152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-17 14:20:05
- Reporting Period:
- 2010-11-15
- Filing Date:
- 2010-11-17
- Accepted Time:
- 2010-11-17 14:20:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1352121 | H Raymond Diradoorian | 2525 Dupont Drive Irvine CA 92612 | Evpglobal Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-11-15 | 22,212 | $32.39 | 24,670 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-11-15 | 20,336 | $69.42 | 4,334 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2010-11-15 | 22,212 | $0.00 | 22,212 | $32.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-04-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,693 | Indirect | By 401(k) |
Common Stock | 3,546 | Indirect | By Esop |
Footnotes
- Shares allocated to reporting person's SIP account as of reporting date.
- Shares allocated to the reporting person's ESOP account as of reporting date.
- The option becomes exercisable in four equal annual installments beginning January 24, 2003.